Form 4 for MRNA Moderna
Accepted 2021-09-03 00:00:00 ET · period of report 2021-09-02 · accession 0001127602-21-024846 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-03 | 2021-09-02 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $393.13 | -10.0K | 1.61M | -0.6% | -$3.93M |
| D | 2021-09-03 | 2021-09-02 | MRNA | Hoge Stephen | Pres | M - OptEx | $0.99 | +10.0K | 1.62M | +0.6% | +$9,900 |
| D | 2021-09-03 | 2021-09-02 | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | -10.0K | 347.4K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-02 | S | D | 10,000 | $393.13 | 1,609,597 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-02 | M | A | 10,000 | $0.99 | 1,619,597 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-09-02 | M | D | 10,000 | $0.00 | 347,431 | D | $0.99 · — to 2023-08-19 | 10,000 Common Stock | (F3) This option is fully vested and exercisable. |